TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

One of the most predictable toxicities of autologous stem cell transplantation (ASCT) for multiple myeloma (MM) — even more so than mucositis — is hair loss.

More than a decade of animal data culled from a hematopoietic stem and progenitor cell (HSPC) transplantation model is giving scientists insight into long-term clonal dynamics and other safety and...

Research shows that as pediatric patients >4 years of age with acute lymphoblastic leukemia (ALL) prepare for allogeneic hematopoietic stem cell transplantation, busulfan-based and...

Researchers say pharmacological attenuation of CDC42, a protein coding gene, effectively addresses bone-related problems caused by cytotoxic conditioning required before hematopoietic stem cell...

For patients undergoing hematopoietic cell transplantation (HCT) from a 10/10 HLA-matched unrelated donor, scientists agree that the age of the donor matters more than T-cell epitope DP-matching.

Haploidentical donors are becoming more common for hematopoietic cell transplantations (HCT) in patients with myelofibrosis.